Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Imprimis Pharmaceuticals and SightLife Surgical Sign Agreement for National Launch of Serum Tears™
Wednesday, May 03, 2017Imprimis Pharmaceuticals Inc an ophthalmologyfocused pharmaceutical company and SightLife Surgical a corneafocused organization providing comprehensive services to ophthalmic surgeons announced the signing of an exclusive strategic sales and marketin...
Aries Pharmaceuticals, Inc. Launches Eleview™ for use in Gastrointestinal Endoscopic Procedures
Wednesday, May 03, 2017Aries Pharmaceuticals Inc today announced the launch and commercial availability of its first product Eleview a novel ready to use submucosal injectable composition for use in the easy and safe endoscopic removal of polyps adenomas and early stage ca...
GSK invests $139 million to expand production capacity for BENLYSTA (belimumab) in Rockville, MD
Tuesday, May 02, 2017GSK announced million of new investment in its biopharmaceutical manufacturing site in Rockville MD to support growing demand for BENLYSTA belimumab for adult patients with active autoantibodypositive systemic lupus erythematosus SLE who are receivi...
Shire and Parion Sciences Enter into a Collaborative License Agreement to Advance P-321 for Ophthalmic Indications
Tuesday, May 02, 2017Shire plc and Parion Sciences Inc announced they have entered into an agreement granting Shire exclusive worldwide rights to develop and commercialize P Shire will lead development of P an investigational epithelial sodium channel ENaC inhibitor for...
NEUROTROPE Announces Positive Top-Line Results From Phase 2 Study of Bryostatin-1 for Moderate to Severe Alzheimer's Disease
Monday, May 01, 2017Neurotrope Inc today announced positive topline results from its Phase study Study of Bryostatin in patients with moderate to severe Alzheimers disease AD a population not commonly targeted in AD clinical trials Bryostatin a Protein Kinase C epsilo...
Takeda Announces FDA Accelerated Approval of ALUNBRIGTM (brigatinib)
Saturday, April 29, 2017Takeda Pharmaceutical Company Limited announced that ALUNBRIG brigatinib has received Accelerated Approval from the US Food and Drug Administration FDA for the treatment of patients with anaplastic lymphoma kinasepositive ALK metastatic nonsmall cell...
Allergan Successfully Completes ZELTIQ® Aesthetics Acquisition
Saturday, April 29, 2017Allergan plc a leading global biopharmaceutical company today announced it has successfully completed the acquisition of ZELTIQ Aesthetics Inc a medical technology company behind a proprietary controlledcooling fat reducing treatment CoolSculpting Al...
Savara Announces Closing Of Merger With Mast Therapeutics
Friday, April 28, 2017Savara Inc a clinicalstage specialty pharmaceutical company focused on the development and commercialization of novel therapies for the treatment of serious or lifethreatening rare respiratory diseases today announced the closing of its previously an...
BridgeBio Pharma Launches Eidos Therapeutics to Develop Targeted Therapy for Fatal Heart Disease
Friday, April 28, 2017BridgeBio Pharma announced the launch of Eidos Therapeutics a biopharmaceutical company developing a novel smallmolecule treatment for transthyretin TTR amyloidosis BridgeBio has committed million and seasoned RD executives to advance Eidos lead com...
The Medicines Company and Alnylam Pharmaceuticals Announce Agreement with FDA on Phase III Clinical Program for Inclisiran
Thursday, April 27, 2017The Medicines Company and Alnylam Pharmaceuticals Inctoday announced that The Medicines Company has agreed with the US Food and Drug Administration FDA on plans for the Phase III clinical program for inclisiran which is designed to support the submis...
